Rhumbline Advisers Phibro Animal Health Corp Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Phibro Animal Health Corp stock. As of the latest transaction made, Rhumbline Advisers holds 76,098 shares of PAHC stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,098
Previous 81,227 6.31%
Holding current value
$1.65 Million
Previous $1.36 Million 25.7%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$16.39 - $22.5 $84,064 - $115,402
-5,129 Reduced 6.31%
76,098 $1.71 Million
Q2 2024

Aug 01, 2024
BUY
$12.44 - $18.55 $5,473 - $8,162
440 Added 0.54%
81,227 $1.36 Million
Q1 2024

May 09, 2024
SELL
$10.63 - $13.68 $24,225 - $31,176
-2,279 Reduced 2.74%
80,787 $1.04 Million
Q4 2023

Feb 08, 2024
BUY
$9.59 - $12.91 $56,533 - $76,104
5,895 Added 7.64%
83,066 $961,000
Q3 2023

Nov 09, 2023
BUY
$12.43 - $15.29 $31,149 - $38,316
2,506 Added 3.36%
77,171 $985,000
Q2 2023

Aug 08, 2023
BUY
$12.92 - $15.89 $105,969 - $130,329
8,202 Added 12.34%
74,665 $1.02 Million
Q1 2023

May 11, 2023
BUY
$13.67 - $16.37 $47,803 - $57,245
3,497 Added 5.55%
66,463 $1.02 Million
Q4 2022

Feb 14, 2023
SELL
$12.05 - $15.14 $2,024 - $2,543
-168 Reduced 0.27%
62,966 $844,000
Q3 2022

Nov 10, 2022
BUY
$12.82 - $20.22 $24,601 - $38,802
1,919 Added 3.13%
63,134 $839,000
Q2 2022

Aug 11, 2022
SELL
$17.89 - $20.47 $17,907 - $20,490
-1,001 Reduced 1.61%
61,215 $1.17 Million
Q1 2022

May 12, 2022
BUY
$18.39 - $21.85 $71,298 - $84,712
3,877 Added 6.65%
62,216 $1.24 Million
Q4 2021

Feb 10, 2022
SELL
$18.96 - $22.76 $6,787 - $8,148
-358 Reduced 0.61%
58,339 $1.19 Million
Q3 2021

Nov 12, 2021
SELL
$20.59 - $30.01 $100,726 - $146,808
-4,892 Reduced 7.69%
58,697 $1.26 Million
Q2 2021

Aug 05, 2021
SELL
$24.15 - $30.08 $129,033 - $160,717
-5,343 Reduced 7.75%
63,589 $1.84 Million
Q1 2021

May 06, 2021
BUY
$19.71 - $25.23 $35,004 - $44,808
1,776 Added 2.64%
68,932 $1.68 Million
Q4 2020

Feb 10, 2021
BUY
$16.44 - $20.2 $112,498 - $138,228
6,843 Added 11.35%
67,156 $1.3 Million
Q3 2020

Nov 12, 2020
SELL
$17.36 - $26.36 $54,059 - $82,085
-3,114 Reduced 4.91%
60,313 $1.05 Million
Q2 2020

Aug 13, 2020
SELL
$22.31 - $28.29 $82,234 - $104,276
-3,686 Reduced 5.49%
63,427 $1.67 Million
Q1 2020

May 06, 2020
BUY
$17.75 - $27.72 $20,980 - $32,765
1,182 Added 1.79%
67,113 $1.62 Million
Q4 2019

Feb 05, 2020
BUY
$21.0 - $24.83 $59,598 - $70,467
2,838 Added 4.5%
65,931 $1.64 Million
Q3 2019

Oct 23, 2019
BUY
$20.34 - $32.66 $35,086 - $56,338
1,725 Added 2.81%
63,093 $1.35 Million
Q2 2019

Aug 14, 2019
BUY
$28.03 - $36.85 $67,243 - $88,403
2,399 Added 4.07%
61,368 $1.95 Million
Q1 2019

May 01, 2019
BUY
$28.71 - $33.65 $17,513 - $20,526
610 Added 1.05%
58,969 $1.95 Million
Q4 2018

Jan 31, 2019
BUY
$31.18 - $44.64 $302,414 - $432,963
9,699 Added 19.93%
58,359 $1.88 Million
Q3 2018

Nov 07, 2018
SELL
$42.3 - $53.5 $7,487 - $9,469
-177 Reduced 0.36%
48,660 $2.09 Million
Q2 2018

Aug 06, 2018
BUY
$38.7 - $48.1 $118,809 - $147,667
3,070 Added 6.71%
48,837 $2.25 Million
Q1 2018

May 02, 2018
BUY
$32.2 - $40.45 $88,517 - $111,197
2,749 Added 6.39%
45,767 $1.82 Million
Q4 2017

Feb 09, 2018
BUY
$32.65 - $37.9 $183,264 - $212,732
5,613 Added 15.01%
43,018 $1.44 Million
Q3 2017

Nov 06, 2017
BUY
$35.0 - $40.0 $1.31 Million - $1.5 Million
37,405
37,405 $1.39 Million

Others Institutions Holding PAHC

# of Institutions
148
Shares Held
20.4M
Call Options Held
0
Put Options Held
0
View Full List

About PHIBRO ANIMAL HEALTH CORP

PAHC Quotes by TradingView
  • Ticker PAHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,337,600
  • Market Cap $440M
  • Description
  • Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...
More about PAHC
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email